Strengthening key health measures in national climate plans

The majority of national climate adaptation plans fail to fully integrate health needs or engage populations most at risk from climate change, according to a new study.

Insular cortex linked to brain stimulation’s antidepressant effects

A circuit that runs from the prefrontal cortex to the insular cortex appears to mediate the antidepressant effects of a newer form of transcranial magnetic stimulation, according to a study led by Weill Cornell Medicine investigators.

Protecting heart health in an era of temperature extremes

Extreme heat and cold are growing cardiovascular risks that can trigger heart attacks, strokes, heart failure and sudden cardiac death, according to a recent scientific statement by experts at Weill Cornell Medicine and other leading institutions.

A breakthrough single-cell method for mapping DNA-protein interactions

A new technology allows scientists to map the DNA-binding sites of transcription factors and other regulatory proteins that control gene activity, according to a study led by Weill Cornell Medicine and the New York Genome Center.

Oral drug combination eases treatment burden for AML patients

A clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia is an effective alternative to the current standard, which requires repeated hospital or office visits for intravenous treatment.

Grant aims to transform care for young cancer survivors

Weill Cornell Medicine received a five-year, $5 million grant from the National Cancer Institute to develop innovative support strategies for an understudied group of cancer patients: adolescents and young adults. 

MRI approach improves assessment of common valve disease

Study supports the broader use and further study of the new metric known as effective right ventricular ejection fraction.

OneCornell health educators conference inspires teaching excellence across disciplines

More than 150 educators gathered in-person and virtually May 16-17 at Weill Cornell Medicine for the OneCornell Health Educators Conference.

Around Cornell

Targeting inflammation may help overcome drug resistance in colon cancer

Targeting tumor-specific inflammatory processes in colorectal cancer could enhance the efficacy of some anticancer therapies and prevent drug resistance, Weill Cornell researchers have found.